Literature DB >> 10632672

Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms.

M N Sato1, P Minoprio, S Avrameas, T Ternynck.   

Abstract

We have previously observed that aged lupus-prone (NZB/NZW)Fl (BWF1) mice when infected with Plasmodium chabaudi show an improvement in their clinical lupus-like symptoms. In order to study the mechanisms involved in the long-lasting protective effect of the P. chabaudi infection in lupus-prone mice we analysed specific aspects of the cellular response, namely the profiles of cytokine mRNA expression and cytokine secretion levels in old BWF1 mice, in comparison with uninfected age-matched BWF1 mice and infected or uninfected BALB/c mice. Two months after infection, cells from BWF1 mice were stimulated with concanavalin A (Con A) and demonstrated a recovery of T cell responsiveness that reached the levels obtained with BALB/c cells. Old BWF1 mice showed high levels of interferon-gamma (IFN-gamma) and IL-5 production and correspondingly low levels of IL-2 and IL-4 secretion before infection with P. chabaudi. Infection did not modify the IFN-gamma levels of BWF1 T cells, whereas it considerably increased the secretion of the Th2-related cytokines IL-4, IL-5 and IL-10. In addition, only BWF1 T cells showed increased mRNA expression of tumour necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta). This counter-regulatory cytokine network of infected BWF1 mice may be involved in the improvement of their lupus symptoms. The results of our investigations using the complex model of P. chabaudi infection can be extended and, by using more restricted approaches, it may be possible to explain the multiple regulatory defects of lupus-prone mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632672      PMCID: PMC1905516          DOI: 10.1046/j.1365-2249.2000.01124.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples.

Authors:  J S Abrams; M G Roncarolo; H Yssel; U Andersson; G J Gleich; J E Silver
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

2.  First-strand cDNA synthesis primed with oligo(dT).

Authors:  M S Krug; S L Berger
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudi.

Authors:  T Ternynck; P B Falanga; C Unterkirscher; J Gregoire; L P da Silva; S Avrameas
Journal:  Int Immunol       Date:  1991-01       Impact factor: 4.823

4.  Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice.

Authors:  E Murphy; S Hieny; A Sher; A O'Garra
Journal:  J Immunol Methods       Date:  1993-06-18       Impact factor: 2.303

5.  Comparison of natural antibodies to autoantibodies arising during lupus in (NZB x NZW)F1 mice.

Authors:  B Hentati; T Ternynck; S Avrameas; B Payelle-Brogard
Journal:  J Autoimmun       Date:  1991-04       Impact factor: 7.094

6.  Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice.

Authors:  M M Stevenson; M F Tam
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice.

Authors:  C Gordon; G E Ranges; J S Greenspan; D Wofsy
Journal:  Clin Immunol Immunopathol       Date:  1989-09

8.  Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell.

Authors:  Y Watanabe; C O Jacob
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

9.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.

Authors:  C O Jacob; H O McDevitt
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

10.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

View more
  4 in total

1.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

Review 2.  Glomerulonephritis, Th1 and Th2: what's new?

Authors:  P G Tipping; A R Kitching
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

3.  The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.

Authors:  Uri Sela; Amir Sharabi; Molly Dayan; Rami Hershkoviz; Edna Mozes
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

Review 4.  SLE: Another Autoimmune Disorder Influenced by Microbes and Diet?

Authors:  Qinghui Mu; Husen Zhang; Xin M Luo
Journal:  Front Immunol       Date:  2015-11-30       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.